CD4 and melanoma: In this same study, B16 melanoma cells increased MHC-II expression in vivo in an IFNγ-dependent manner, and the adoptively transferred CD4+ T cells could kill tumor cells in vitro and reject challenge tumors in vivo in an MHC-II-dependent manner (22).